Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium vs Paroxetine in MDD with Bipolar Family History
NCT01416220Phase 4Withdrawn
- Sponsor
- Nova Scotia Health
- Start
- Sep 2011
- Primary completion
- Feb 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lithium in major depressive disorder (MDD), sponsored by Nova Scotia Health. Planned start Sep 2011; status: withdrawn.
02
Drugs
lithium
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01416220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01416220.